Chris leads day to day commercial CAR-T manufacturing operations at the BMS site in Bothell, delivering autologous therapies to patients globally. He also works with the company’s larger cell therapy network to set the strategic direction for the site, to maximize the reach of commercially available cell therapies for patients and support the growth of its cell therapy pipeline. Chris is a chemist, turned engineer with 25+ years of experience working in the Pharma, Biologics & CGT sectors. After starting and growing his career in Europe, he has spent the last 10 years in the US in a variety of leadership roles in manufacturing operations.
Track Chair: Sharon Benzeno, Adaptive Biotechnologies